Prenatal screening programmes have been critiqued for their routine implementation according to clinical rationale without public debate. A new approach, non-invasive prenatal diagnosis (NIPD), promises diagnosis of fetal genetic disorders from a sample of maternal blood without the miscarriage risk of current invasive prenatal tests (e.g. amniocentesis). Little research has investigated the attitudes of wider publics to NIPD. This study used Q-methodology, which combines factor analysis with qualitative comments, to identify four distinct 'viewpoints' amongst 71 UK men and women: 1. NIPD as a new tool in the ongoing societal discrimination against the disabled; 2. NIPD as a positive clinical application offering peace of mind in pregnancy; 3. NIPD as a medical option justified for severe disorders only; and 4. NIPD as a valid expansion of personal choice. Concerns included the 'trivialization of testing' and the implications of commercial/direct-to-consumer tests. Q-methodology has considerable potential to identify viewpoints and frame public debate about new technologies.
'Non-invasive prenatal diagnosis (or NIPD) is the term for a new approach to genetic prenatal diagnosis. NIPD technologies are at various stages of development, but as a collective, aim to offer earlier, easier and less risky genetic testing of the fetus through maternal blood with the potential to replace current diagnostic pathways (e.g. for Down's syndrome diagnosis) and widen prenatal testing possibilities (Hahn & Chitty, 2008) . NIPD technologies have raised considerable debate within bioethical and social scientific communities, but with little attention within public 1 spheres to date. This paper reports findings from an ESRC funded study of public attitudes towards NIPD. It was conducted in the UK, where prenatal testing is a well-established aspect of obstetric care, and the small amount of media reporting of early NIPD trials has been largely positive.
Non-invasive prenatal diagnosis
Current screening pathways for common genetic disorders move progressively from noninvasive towards invasive techniques. Non-invasive technologies such as ultrasound are used initially to screen pregnancies. Those identified as 'high risk' are subsequently offered diagnosis through invasive techniques such as amniocentesis or chorionic villus sampling (CVS). These carry a small but significant miscarriage risk (Caughey, Hopkins et al. 2006) and are usually conducted from 15 weeks onwards. One goal of NIPD is to replace this two-step pathway with a one-step early less risky diagnostic test by taking blood from the pregnant woman to analyse the genetic information of the fetus. Non-invasive techniques have been driven by the discovery of 'cell-free fetal DNA ' (cffDNA) and RNA (cffRNA) in maternal plasma during pregnancy (Lo, Corbetta et al. 1997) . This allows the possibility of obtaining definitive genetic information about the fetus for a limited range of conditions (e.g. sex, paternity, chromosomal abnormalities) from 7 weeks into the pregnancy. DNA-based sexidentification for X-linked disorders, Rhesus D testing and single gene disorder testing are already in limited clinical use. The 'Holy Grail' of NIPD is a replacement diagnostic test for chromosomal abnormalities such as Down's syndrome (Hahn and Chitty 2008) . A blood test would also raise the potential of widening diagnostic opportunities rather than restricting them to those at high risk.
A 'simple blood test' for multiple genetic diagnoses also opens up commercial and direct-toconsumer (DTC) opportunities not present in existing invasive test scenarios. Although there are restrictions on sex-determination in clinical settings in the UK, maternal blood tests for sex are available over the internet (e.g. Pink and Blue test offered by Consumer Genetics). This opens the potential for sex selection as well as 'for information only' use. NIPD paternity testing early in pregnancy is also currently available on the Internet (e.g.
http://www.dnaplus.com/fetal_cell_prenatal_paternity_test.htm). The validity and reliability of such DTC tests are unknown. Companies including Sequenom have also been highly proactive in driving forward commercial Down syndrome blood tests. Issues of the regulation of DTC NIPD tests remain unresolved. The ease of obtaining a blood sample also raises the possibility of pressure or coercion to test.
At present, NIPD applications are limited by current analytic techniques. However, it is likely NIPD will be used for much wider diagnostic practices in the future, known as 'specification creep' (Hall, Bostanci et al. 2009 ). Possibilities range from testing for most single gene disorders to susceptibility testing for later-onset conditions such as Alzheimers/cancer or for cosmetic 'phenotypic' markers, such as eye colour or muscle (de Jong, Dondorp et al. 2010) . Indeed, in 2010, it was announced that it is possible to sequence the whole fetal genome from maternal blood (Lo 2010) . In summary, NIPD has the potential to considerably expand the fetal genetic information available early in pregnancy without miscarriage risk and to widen access to diagnostic testing.
Public attitudes towards prenatal testing and NIPD
In the United Kingdom (UK), public attitudes are shaped by existing prenatal screening programmes and their regulatory context. Pregnant women in the UK have access to fetal anomaly screening through programmes overseen by the UK National Screening Committee (UKNSC). In the UK, all pregnant women are offered an ultrasound scan as a screening tool for fetal anomalies at around 18-20 weeks. In England, an optional maternal serum biochemical screening test for Down's Syndrome is also offered. The UK is one of 25 out of 27 European Union countries in which termination of pregnancy on grounds of fetal abnormality is permitted.
NIPD is thus not an isolated set of new technologies, but part of a historical lineage of prenatal testing which has been the site of extensive discussion within the social sciences. We draw on this literature to consider how the novel features of NIPD raise new and complex social and ethical issues (Newson 2008; Ravitsky 2009; Schmitz, Netzer et al. 2009 ) and how the public might respond to them.
Firstly, NIPD potentially changes key parameters of prenatal diagnosis. Invasive diagnosis creates much anxiety and ambivalence (Markens, Browner et al. 1999) . For example, ambivalence about diagnostic testing is a key factor when considering whether to 'choose not to choose' for parents who already have an affected child (Kelly 2009 ). Taking away the miscarriage risk is a significant change in the risk equation of obtaining prenatal genetic diagnosis. The processes of screening followed by diagnosis through amniocentesis or CVS, which often move decision-making into the second trimester, has led to the social experience of the 'tentative' pregnancy (Katz Rothman 1986 ).
Processes such as bonding or public disclosure are suspended until approval (in the form of the 'correct result' to diagnostic tests) is given to the 'healthy' fetus. NIPD will move the testing period forward, to early in the first trimester. This is likely to lead to pregnancies being experienced as less tentative, with less anxiety whilst waiting for results, and earlier terminations. It may also increase the termination rate overall, if diagnostic testing becomes widespread. Although attitudes to termination are linked with attitudes towards prenatal testing, they are not synonymous (Bryant, Green et al. 2006) . However, abortion and religious beliefs represent another dimension on which public attitudes are likely to differ (Bell and Stoneman 2000) .
Replacing invasive procedures with a 'simple blood test' could also exacerbate the routinization and normalization of prenatal testing (Press and Browner 1995; Suter 2002) . Seror found that 42% of women who had recently undergone screening for Down Syndrome in France had a 'passive' involvement in the decision; many did not realise that screening was a precursor to decisions about invasive testing and termination (Seror and Ville 2009) . It is not clear, however, whether the public themselves have concerns about their independence in making prenatal testing decisions. A Finnish study of medical and lay attitudes towards genetic testing showed that midwives expressed more concern about autonomy of choice than did lay people (Toivianen, Jallinoja et al. 2003) .
The potential for earlier, easier and less risky NIPD has also reactivated debates about the eugenic potential of such technologies. As the disability critique has argued, the 'new eugenics' operates through giving individuals (limited) choices around what is an acceptable response to disabled fetuses, and through invoking notions of parental responsibility (Parens and Asch 2000; Kerr and Shakespeare 2002) . There are two main objections to abortion on the grounds of disability from this perspective (Parens and Asch 2000) . One, the 'expressivist' argument, perceives termination on the grounds of disability as discrimination to both the disabled fetus but also to those who already have the disability. The second, the 'parental attitude argument', sees selective abortion as representing a fundamentally misguided notion of parenthood as an opportunity to pick and choose the perfect child.
It is unclear to what extent these perspectives might appear in public responses to NIPD.
The notion of 'picking and choosing' one's children is further provoked by the considerable commercial and DTC possibilities opened up by NIPD. It is not clear how different publics would view obtaining commercial or online genetic diagnoses outside traditional medical pathways; as part of the 'commodified pregnancy' process of quality control (Rothman 1988) or as part of an empowerment of parents, giving them the right to choose without health professional involvement (Modra 2006) .
Commercial NIPD also raises the possibility of increased terminations for non-medical reasons (e.g. for sex selection or paternity) about which the public remain highly ambivalent (Scully, Banks et al. 2006 ).
To date, most studies of public attitudes towards prenatal testing in general, and NIPD in particular, have involved only women, those in high-risk pregnancies, or parents and families with existing genetic disorders. One study of attitudes towards NIPD amongst pregnant women who had recently undergone invasive diagnosis found that approximately half would still want the confirmation of an invasive diagnosis even if they had a desirable NIPD result (Zamerowski, Lumley et al. 2001 ).
Another study with pregnant women and female medical students showed the majority were positive about seeing NIPD as an asset in prenatal care, but not for sex selection (Kooij, Tymstra et al. 2009 ).
Little is known about how wider publics might think about the introduction of NIPD. This study set out to investigate public viewpoints of NIPD amongst those often selected in study samples, but also amongst those who are not (men, the child-free, older/younger individuals, those with little experience of genetic disorders or disabilities). There is no doubt that medical and scientific experts are powerful actors in framing the social desirability of a given innovation (Lehoux, Denis et al. 2010) . However, it is the wider societal group who set the backdrop for the acceptance or resistance of new and emerging technologies such as NIPD. Furthermore, the implementation of routine prenatal screening programmes on the basis of clinical rationale and technological possibilities without extensive public debate has been extensively critiqued (e.g. Katz Rothman, 1986; Suter, 2002 Method Given the right method, lay people can produce sophisticated and relevant moral arguments about modern reproductive technologies (Scully, Banks et al. 2006) . Q-methodology is a wellestablished, if not well-known method which has been used to study public attitudes towards health behaviours and technologies (e.g. Caughey, Hopkins et al., 2006; Farrimond, Joffe et al., 2010) . In a Qsort, participants are asked to sort statements on a topic into a pattern along a dimension of agreement/disagreement (as shown in Figure I ). Statements are sorted in relation to each other, so that participants create their 'holistic' viewpoint on the topic (Stenner, Watts et al. 2008) . Participants are free to sort in a way that may appear inconsistent or reveals ambiguities (Stainton Rogers 1995). The whole sorts are then correlated and factor-analysed (by-person) to identify groups of sorts which are similar at above chance levels of probability. The end result is a set of statistically independent 'viewpoints' or 'understandings' of a 'limited independent variety ' (Keynes 1921) . This fits with a social constructionist perspective that individuals within a society are likely to understand a topic using multiple (but not infinite) sets of socially shared discourses (Stainton Rogers 1991) . A previous Qmethodology study on Down's syndrome found differences in understandings over the perceived normality of children with the syndrome as well as over the desirability of termination for this condition (Bryant, Green et al. 2006 ).
We contend that Q-methodology is a method which has much to offer the investigation of how societies and publics perceive new technologies. Methodologically, 'researching the future' is problematic. The term 'NIPD' covers a set of diverse and complex technologies, currently little or unknown to the public. Qualitative methods such as in-depth interviews or focus groups were not suitable given the lack of prior knowledge of the topic. Surveys have been extensively used to tap public attitudes towards technologies such as prenatal testing (e.g. (Singer 1993) . Although useful for gaining a broad-brush public opinion, they may provoke a superficial response to limited choice answers. Singer also points out that the scales for prenatal testing are quite unreliable which may be due to unfamiliarity with the topic (in the early 1990s); their lack of stability may also reflect ambivalence on the part of participants. Another set of methodological techniques involve collecting together citizens for deliberation, in citizen's juries and consensus conferences, to discuss controversial topics such as xenotransplantation (Einsiedel 2002) or food technology (Einsiedel, Jelsoe et al. 2001 ).
Q-methodology does not attempt to reconfigure the relationship between policy-makers and the public in a direct sense, but rather 'take the temperature' of attitudes at a given time-point. It also does not focus primarily on consensus, but rather seeks to expose significant differences in viewpoints. Qmethodology was used her to give participants time to explore the issue at hand, in reaction to preexisting statements (so no prior knowledge required) and with the potential to explore ambiguity and contrasting views.
Sampling the 'concourse'
In Q-methodology, the statements form the sample. These are taken from the concourse, the population of ideas, knowledge, debates, discourses and images on the topic. In this study, the concourse included of medical, academic and media texts on NIPD. As there were few pre-existing public discourses about NIPD, material was sampled and adapted from discussions of prenatal testing, genetic disorders and disabilities in childhood (e.g. web responses to media articles, interview material conducted with parents of children with genetic conditions (Kelly, 2009) ). Both authors reviewed the source material and created lists of statements separately, before combining them to generate 157 initial statements.
Statements taken from articles/interview were often used verbatim rather than being modified extensively by the authors. The aim was to generate statements using real-life language (e.g. not always removing morally laden terms or controversial positions) to produce authentic responses on the part of participants. These statements were then checked for intelligibility, duplication and balance (Stainton Rogers 1995) and reduced to 70. The Q-sort task was pilot tested. The final set of statements is shown in Appendix I online.
Participants and response rate
The study had a purposive sampling strategy which sought participants with a variety of relevant experiences. Men and women aged 18-60 were recruited via email, the Internet (e.g., Mumsnet), advertisements in public libraries, community groups (e.g. places of worship) and local newspapers.
Participants were given a £15 voucher upon completion of the task.
Ninety-seven participants who responded to the initial invitation were sent packs. Seventy-three were returned, but two sorts were incomplete and excluded from the study, leaving 71 complete sorts (73% response rate).
The characteristics of participants are shown in Table 1 .
Procedure
The research was approved by the Humanities and Social Sciences Ethics Committee, University of Exeter.
The study was carried out by post. After replying to our advertisements, participants were sent a study pack comprising consent forms, the 70 numbered statements on small cards and a study booklet with step-by-step instructions. The study booklet included an introductory paragraph about NIPD to be read before sorting. This briefly described what NIPD was and how it was likely to differ from current prenatal screening (earlier, diagnostic, avoiding the physical risks of amniocentesis, potentially available for a wide range of genetic conditions and commercial use). This paragraph was pilot tested for neutrality and comprehensibility. Participants were then asked for their 'first thoughts' on NIPD in an open comment box before doing the sorting task. Participants were asked to arrange the statements in a fixed distribution according to how much they agreed (+6), disagreed (-6) or were neutral (0) 
Analysis
In Q-methodology, the whole sort is correlated with the other whole sorts; a 'by person' factor analysis (unlike traditional correlation in which individual items are correlated with the sample) (Brown 1980 ).
We used PCQ (www.pcqsoft.com). Initially, all 71 Q-sorts were inter-correlated in a large matrix. This matrix was then factor analyzed and rotated using the orthogonal varimax procedure (see Brown, 1980 for the merits of various types of rotation) to produce a set of discrete (not overlapping) factors. Each factor represents a statistically different 'view' on NIPD.
In deciding on the number of factors to retain for rotation, we balanced the amount of variance explained against parsimony (simplicity). We tried a three, four and five factor model. The four factor model was judged best against this criterion, explaining 48% of the variance. Individual Q-sorts or 'exemplars' loaded significantly onto one of the factors at 0.4 (p<0.01). Factor One had 27 exemplars (21% of the variance), Factor Two had 20 (16% ), Factor Three had 6 (7% ) and Factor Four had 3 exemplars (4% ). Eight 'confounding' sorts which loaded onto more than one factor were excluded, as were seven non-loading sorts. To be able to interpret each factor, the sorts of all the participants who held that viewpoint were merged together using a weighted averages method (see Brown, 1980; Stenner, Watts and Worrell, 2008) . This produced four 'arrays' or ideal examples of that particular factor on NIPD (e.g. Factor One's array is shown in Figure I ). Table I shows the arrays for all four
Factors. Both Table I and Figure I are available in an appendix online.
Interpreting the factors
Each factor/viewpoint was interpreted by looking at the factor arrays to identify the key statements.
These are those ranked at the extremes (i.e. strongly agreed or disagreed with), or those ranked differently compared with the others. 2 In the interpretation, the key statements for each factor are identified in bold. They are also denoted by a) the number of statement and b) the + or -ranking of the statement in that viewpoint. So (8: +6) means that Statement 8 'These new tests should only be used to find out about serious medical conditions' is strongly agreed with in that viewpoint, ranked as +6.
Statements everyone agreed on (consensus statements) are also identified. To further aid interpretation, comments of participants who held each viewpoint are included in italics.
Findings FACTOR ONE: NIPD as discrimination against the disabled
Factor One represents the viewpoint of twenty-seven participants (19 female, 8 male, average age = 41). Eighteen had children. Thirteen had no experience of severe disability or genetic conditions; three had close relatives/friends with a disability, four had experience through work (e.g., special educational needs, speech therapy), two described themselves as disabled (spina bifida and cerebral palsy), and five had children with disabilities (including Downs syndrome, autism and microcephaly).
Factor One holds NIPD 'to be a form of discrimination against disabled people' (39: +4* 
FACTOR THREE: NIPD for severe disorders only
Factor Three represents the position of six participants, five women and one man. Their average age was 45. Two had no children. Three had no experience of disability or genetic conditions; the other three had relatives/friends with affected children or conditions (e.g. nephew with severe autism).
Factor Three shares aspects of both Factor One and Factor Two. As in Factor One, there is considerable concern over the social implications of NIPD, particularly the trivialization (9: +5) and routinization of 
I think the internet is the wrong place to go for this information as there may be a need for counseling of the results' (P62).

FACTOR FOUR: NIPD as a personal choice
Factor Four represents the views of three participants. Two were female, one male. Their average age was 33 years old. They all had children, one having a partner who was seven months pregnant, and one was pregnant. Two had no experience of severe disability/genetic conditions, and one had a cousin with Down's syndrome.
Whereas the notion of 'parental choice' was rejected in Factor Three, here it is a central value. From this 'choice' perspective, the notion of designer babies is not held to be inherently wrong or offensive (unlike in other Factors) (6:-3*). The desirability of parental choice isn't based on a fear of a lack of tolerance towards disabled individuals: there is a perception that society is more accepting of disabled people than fifty years ago (43: +5*). However, making choices about whether to have a disabled child is conceptualized as a personal choice for that family, not in terms of social impact: 'parents should have the opt-out-some people will cope better than others' (P37, male, partner pregnant). Perhaps because of the stress on individual decision-making, there is an emphasis on the importance of good genetic counseling (29: +6) on the understanding that having these tests will give you 'peace of mind' (27: +4).
Consensus Statements
Some statements were so controversial that participants across the factors agreed with each other in strongly supporting or rejecting them. Firstly, all participants disagreed with the idea that 'a damaged baby is a damaged family, however sad that sounds ' (46) . There was also a strong rejection of the idea of compulsory testing, either for 'societal 'reasons or for those on benefits (66, 70): 'such measurement recalls Nazi procedures and should not be given thought' (P44, male, four children).
There was also a consensus that fathers shouldn't be excluded from making decisions about NIPD (48).
Finally, all participants rejected the notion that parents should be able to have these tests directly without going through a hospital or doctor (56): 'would be a major problem in terms of interpreting results' (P64, female, three children).
Discussion:
The findings reveal four major viewpoints in this UK sample about non-invasive prenatal diagnosis as an emerging set of technologies. From these different viewpoints, the potential clinical characteristics of NIPD, such as less risky, earlier and expanded diagnostic testing of the fetus, were viewed in several ways; as a clinical application offering peace of mind (Factor Two), as an opportunity to actualize parental choice (Factor Four), as a medical pathway needing to be restricted to severe genetic disorders (Factor Three) and as a new technology which would lead to the exacerbation of discrimination against the disabled (Factor One). A 'consensus of concern' existed about NIPD being available outside traditional clinical pathways (e.g. commercially/DTC). This discussion considers how we can make sense of these complex and multiple viewpoints from a psycho-social perspective, as well as considering the utility of Q-methodology to investigate public understandings of new technologies.
The benefits of NIPD, in terms of less risky, earlier and easier testing, are seen as distinct advantages in more than one viewpoint. It is interesting to note that despite generalized fears about the societal consequences of NIPD, the idea of replacing amniocentesis with a maternal blood test is not rejected outright even within the first viewpoint (Factor One) and is strongly supported in the others.
Factor Two most strongly articulates the benefits of NIPD, broadly in line with the 'safer, easier, earlier' clinical and scientific rationale for developing NIPD (e.g. (Hahn and Chitty 2008) . Participants ranked several statements relating to earlier diagnosis very positively, articulating a variety of benefits ranging from 'for information only', to allowing preparation for the birth of a disabled child, to earlier termination. Earlier diagnosis was framed as allowing 'peace of mind'. Katz Rothman's work has shown how current invasive prenatal technologies, such as amniocentesis, have reconstructed the prenatal period as tentative one, full of anxiety and stress, in which reassurance only comes in the form of technologically obtained knowledge. Factor Two articulates the potential advantages of NIPD in terms of this tentative world: NIPD would offer earlier definitive (diagnostic) knowledge, and thus the opportunity for reassurance much earlier in the pregnancy. This is a relatively individualistic rationale for NIPD which fits (as does Factor Four) within a framework in which more genetic information is seen to offer greater 'choice' and 'peace of mind' to autonomous individuals and families (Petersen 2002 ).
However, this ability to choose is also reconstructed, in other viewpoints, in a negative way, as a fear that the expansion of genetic testing possibilities through NIPD will lead to the 'trivialization of termination. Interestingly, although fears about trivialization were strong, few participants supported expanding diagnosis for non-medical reasons such as sex selection or paternity, with only the minority position Factor Four supporting this on the grounds of parental choice.
From the perspective of Factor One, NIPD is not a unique set of technologies. Rather, it must be viewed as part of a longer history of prenatal technologies which have, as identified by Parens and Asch (2000; also Kerr and Shakespeare, 2002) , discriminated against the disabled through the practice of selective abortion. NIPD as part of the 'new eugenics' thus finds continuity, at least for a proportion of the public, with the old. The identification of the 'disability critique' viewpoint in this sample is not a trivial one. Kerr and Shakespeare have argued that these voices are often marginalized or drowned out by more dominant clinical and medical discourses in debates about new genetic technologies.
Although the four viewpoints framed NIPD differently, there was also a 'consensus of concern' about the commercial/DTC potential of a diagnostic technology which only requires a small sample of blood (and not the pregnant woman present). The key objection to online or commercial testing was the possibility of prenatal diagnosis outside traditional medical pathways, without the involvement of a health professional. Several reasons were given for this. Firstly, many participants envisaged health professionals as the appropriate group to make decisions about who should access tests and which tests should be available. Health professionals are thus seen as a limiting force against the trivialization of testing. Secondly, many participants saw a need for professional expertise to interpret genetic results and to offer counseling. Placing diagnostic prenatal testing directly in consumers' hands is not seen either desirable or a form of patient empowerment. Participants saw clinicians as a paternalistic 'buffer' against the excesses of commercialism in prenatal testing, rather than as a controlling interest aligned with market forces in the new genetics (Kerr and Cunningham-Burley 2000) . This study raises the question of whether there is indeed an appetite for commercial/DTC NIPD amongst different publics, and how they think it should be regulated This study also supports our contention that Q-methodology is a valuable tool to tap public opinion about complex future technologies. It gave participants an opportunity to critically consider the social, ethical and legal issues around NIPD, simultaneously informing them about the topic and exposing them to a range of values and views, allowing them to form and express their own viewpoint.
It exposed differences in views as well as areas of consensus, suggesting directions for public engagement on the topic (e.g. regarding DTC/online regulation).
Q-methodology does have several limitations. One is that it does not tend to involve random sampling, meaning that is not possible to ascertain the prevalence of each viewpoint in the general population. In terms of a response bias, it may be the case that those with strong views or relevant experiences about disability, genetic testing or abortion were particularly motivated to participate.
However, looking at the participants' characteristics table (Table II) , it can be seen that approximately 50% of participants had no prior experience of severe disability, genetic conditions or prenatal screening. Our purposive strategy also ensured groups often under-represented in public attitudes to prenatal testing samples, such as men and those without children, also participated.
Q-methodology is not a direct approach to public participation in decision-making processes, as intended with methods such as consensus conferences (although as Einseidel et al. 2001 acknowledges, they often do not have direct impact on policy). Rather it offers an alternative tool for identifying public opinion on complex or controversial technologies, cohered into a set of distinct 'viewpoints.' It has particular utility for identifying minority as well as majority viewpoints (Farrimond, Joffe et al. 2010) . In this study, Factor Four is a minority position, one that might easily be lost within a largescale survey. One use of Q-methodology, therefore, would be as the basis upon which to develop a larger-scale public inquiry aiming to incorporate representation from all of the identified 'viewpoints'.
As such, it can offer a framework for thinking through and stimulating public debate to feed into policy and clinical spheres 3 .
We do not claim, however, to have exhaustively identified all possible viewpoints from the UK 
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